Shukra Pharmaceuticals Q2 Results FY27: Profit Jumps 434.03% to Rs 12.71 Cr, Revenue Rs 44.20 Cr, PAT Rs 12.71 Cr

Shukra Pharmaceuticals Ltd (SHUKRAPHAR) Q2 Results FY27 announced on 4 November 2026, covering the company's financial performance for the July to September quarter. The results date brings consolidated results showing revenue of Rs 44.20 Cr and net profit of Rs 12.71 Cr, and Shukra Pharmaceuticals Q2 Results FY27 anchor every figure in this article. Univest follows the filing on NSE and BSE.

This Shukra Pharmaceuticals Q2 Results results analysis covers the financial highlights, the business factors on record, the outlook and the risks that investors can verify. It opens with the Financial Highlights table, which sets the latest quarter beside the same quarter of last year.

Click Here – Get Free Investment Predictions

Shukra Pharmaceuticals Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 44.2 Cr	Rs 5.88 Cr	+651.7% YoY
Net Profit (PAT)	Rs 12.71 Cr	Rs 2.38 Cr	+434.03% YoY

Source: company filing for Shukra Pharmaceuticals Q2 Results FY27, 4 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Shukra Pharmaceuticals Q2 Results: What Stands Out

• Revenue of Rs 44.20 Cr compares with Rs 5.88 Cr in the year-ago quarter, a YoY growth reading of 651.7% on a Consolidated basis.
• Net profit of Rs 12.71 Cr compares with Rs 2.38 Cr a year earlier, which puts the rise at 434.03% across the two quarters.
• Return on equity of 29.94% for FY26 is the annual ratio on record and gives a longer reference than the single quarter.
• Net profit margin of 28.8% is listed against 40.5% in the comparison quarter, so profit grew by less than revenue.
• The performance analysis in Shukra Pharmaceuticals Q2 Results FY27 now sets out how revenue and net profit moved against each other.

Shukra Pharmaceuticals Q2 Results FY27: Performance Analysis

The numbers show Consolidated revenue of Rs 44.20 Cr against Rs 5.88 Cr a year earlier, and net profit of Rs 12.71 Cr against Rs 2.38 Cr. Revenue grew 651.7% and net profit grew 434.03%, so both lines moved sharply higher, with revenue moving by the larger percentage.

Net profit rose by less than revenue in percentage terms, which is why the net profit margin reads 28.8% against 40.5% in the comparison quarter. This YoY growth comparison relies only on the two quarters named, and it does not by itself establish the cause behind the difference.

For Shukra Pharmaceuticals Q2 Results FY27, the consolidated results show both lines well above the prior-year base. Readers following the results analysis for Shukra Pharmaceuticals should watch whether the next filing keeps revenue near Rs 44.20 Cr, which leads into the business factors on record.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis starts with revenue, which grew 651.7% year on year to Rs 44.20 Cr in the latest quarter. This is the top line behind the quarterly results and sets the base for the profit figures.

Net Profit Rise – Net profit rose 434.0% year on year to Rs 12.71 Cr. The gain sits beside the revenue increase and is the figure that most directly shapes the profit picture in Shukra Pharmaceuticals Q2 Results FY27.

Return on Equity – Return on equity was 29.94% in FY26. This is a full-year ratio, so it describes the earlier annual period and not the July to September quarter, though it gives a longer reference for the profit figures.

FY27 Outlook After Shukra Pharmaceuticals Q2 Results

No management guidance is attached to Shukra Pharmaceuticals Q2 Results, so the FY27 outlook depends on the filings still to come. Full-year FY27 results will reflect how revenue and net profit develop after the July to September quarter, along with sector conditions as they are disclosed.

The results analysis for FY27 begins from revenue of Rs 44.20 Cr and net profit of Rs 12.71 Cr. Later filings will show whether net profit holds near that level, and the risks below set out what to track alongside it, including how the margin has shifted.

Key Risks to Watch After Shukra Pharmaceuticals Q2 Results FY27

Narrower Net Profit Margin

Net profit margin narrowed to 28.8% from 40.5% in the comparison quarter. For Shukra Pharmaceuticals Q2 Results FY27 this is the main caution, because net profit grew by a smaller percentage than revenue.

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs -1.72 Cr to Rs 20.37 Cr over the last 5 quarters. That wide range means the latest figure of Rs 12.71 Cr is one point in an uneven sequence.

Lower Profit Than Previous Quarter

Net profit was down 1.9% quarter on quarter from Rs 12.96 Cr. This sequential dip is small, and it is a different comparison from the YoY growth reported across the rest of this article.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

The quarterly results declared on 4 November 2026 show Consolidated revenue of Rs 44.20 Cr and net profit of Rs 12.71 Cr, with revenue up 651.7% and net profit up 434.03% year on year. Shukra Pharmaceuticals Q2 Results FY27 show both lines far higher, and Shukra Pharmaceuticals Q2 Results are best read alongside later filings. Consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Shukra Pharmaceuticals Q2 Results FY27

What are Shukra Pharmaceuticals Q2 Results FY27?

Ans. Shukra Pharmaceuticals Q2 Results FY27 are the July to September 2026 Consolidated figures, with revenue of Rs 44.20 Cr and net profit of Rs 12.71 Cr, as set out in the Quick Answer above.

What is the results date for Shukra Pharmaceuticals Q2 Results FY27?

Ans. The results date for Shukra Pharmaceuticals Q2 Results FY27 is 4 November 2026, when the company declared its quarter figures, which are compared with the prior-year quarter in the Financial Highlights section.

What revenue was reported in Shukra Pharmaceuticals Q2 Results FY27?

Ans. Shukra Pharmaceuticals Q2 Results FY27 report revenue of Rs 44.20 Cr, compared with Rs 5.88 Cr a year earlier, so the Performance Analysis section reads this as a YoY increase.

What net profit was reported in Shukra Pharmaceuticals Q2 Results FY27?

Ans. Shukra Pharmaceuticals Q2 Results FY27 show net profit of Rs 12.71 Cr against Rs 2.38 Cr in the year-ago quarter, which means the Key Takeaways section lists a rise of 434.03%.

How much YoY growth did revenue show in Shukra Pharmaceuticals Q2 Results FY27?

Ans. Revenue YoY growth in Shukra Pharmaceuticals Q2 Results FY27 is 651.7%, with Rs 44.20 Cr against Rs 5.88 Cr, while the Performance Analysis section compares it with the net profit move.

Did net profit rise or fall in Shukra Pharmaceuticals Q2 Results?

Ans. In Shukra Pharmaceuticals Q2 Results net profit rose 434.03% year on year to Rs 12.71 Cr, which means profit grew by less than the revenue increase covered in the Performance Analysis.

What was the year-ago net profit compared in Shukra Pharmaceuticals Q2 Results?

Ans. The year-ago net profit compared in Shukra Pharmaceuticals Q2 Results was Rs 2.38 Cr, so the latest figure of Rs 12.71 Cr is higher, as the Financial Highlights table shows.

Are Shukra Pharmaceuticals Q2 Results consolidated results or standalone results?

Ans. Shukra Pharmaceuticals Q2 Results are consolidated results, so the figures of Rs 44.20 Cr revenue and Rs 12.71 Cr net profit cover the group, as the Performance Analysis section explains.

What business factors shaped Shukra Pharmaceuticals Q2 Results FY27?

Ans. The factors on record for Shukra Pharmaceuticals Q2 Results FY27 are revenue growth of 651.7%, a net profit rise of 434.0% and return on equity of 29.94%, covered in the Key Business Factors section.

What are the key risks after Shukra Pharmaceuticals Q2 Results FY27?

Ans. After Shukra Pharmaceuticals Q2 Results FY27 the risks on record are a narrower margin of 28.8%, volatile quarterly net profit and a small dip from the previous quarter, as the Key Risks section explains.

What is the outlook after Shukra Pharmaceuticals Q2 Results?

Ans. No management guidance accompanies Shukra Pharmaceuticals Q2 Results, so the outlook depends on later quarters, which means the FY27 Outlook section points readers to subsequent filings for direction.

Where can I find the complete Shukra Pharmaceuticals Q2 Results FY27 data?

Ans. The complete Shukra Pharmaceuticals Q2 Results FY27 data sits in the Financial Highlights table above, alongside Univest coverage, so that section is the place to compare each line.